0001104659-20-009340.txt : 20200131
0001104659-20-009340.hdr.sgml : 20200131
20200131170047
ACCESSION NUMBER: 0001104659-20-009340
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200130
FILED AS OF DATE: 20200131
DATE AS OF CHANGE: 20200131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDERSON RICHARD ALLAN
CENTRAL INDEX KEY: 0001266647
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37704
FILM NUMBER: 20565790
MAIL ADDRESS:
STREET 1: 11111 SANTA MONIKA BLVD STE.550
CITY: LOS ANGELES
STATE: CA
ZIP: 90025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DarioHealth Corp.
CENTRAL INDEX KEY: 0001533998
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452973162
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 HATOKHEN ST.
CITY: CAESAREA
STATE: L3
ZIP: 38900
BUSINESS PHONE: (972)-(3)-6222929
MAIL ADDRESS:
STREET 1: 8 HATOKHEN ST.
CITY: CAESAREA
STATE: L3
ZIP: 38900
FORMER COMPANY:
FORMER CONFORMED NAME: LabStyle Innovations Corp.
DATE OF NAME CHANGE: 20111101
4
1
tm206305d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-01-30
0
0001533998
DarioHealth Corp.
DRIO
0001266647
ANDERSON RICHARD ALLAN
8 HATOKHEN STREET
CAESAREA INDUSTRIAL PARK
L3
3088900
ISRAEL
0
1
0
0
President, GM of North America
Employee Stock Option (right to buy)
8.41
2020-01-30
4
A
0
90000
A
2026-01-30
Common Stock
90000
90000
D
Employee Stock Option (right to buy)
8.41
2020-01-30
4
A
0
90000
A
Common Stock
90000
90000
D
The option was granted on January 30, 2020 and provides for vesting as follows: (i) 30,000 shares of common stock vest on first anniversary of the date of grant; and (ii) 60,000 shares of common stock vest in equal quarterly installment during the two year period following the first anniversary of the date of grant, subject to the Reporting Person's continued employment by the company.
The option vests over a three years period commencing on the first day of the relevant following fiscal year, in twelve (12) equal quarterly installments, upon the Company's attainment for each fiscal year ending December 31, 2020 through December 31, 2023, of specified business to business revenues recognized by the Company in the United States, subject in each case to the Reporting Person's continued employment by the company on the applicable vesting date.
/s/ Richard Anderson
2020-01-31